TRANSLATING INNOVATIVE SCIENCE
Into Novel Lupus Therapeutics
Resolve Therapeutics is a private biotechnology company that is dedicated to the goal of improving the lives of patients suffering from lupus.
Resolve Initiates RSLV-132 Clinical Studies
A Proof-of-Concept for Fast Exit Strategy
Takeda and Resolve Therapeutics Enter Autoimmune Partnership
Resolve Therapeutics Raises $5.8 Million in Private Financing
© 2014 Resolve Therapeutics